Apitope Completes Recruitment Into Its Clinical Trial of ATX-MS-1467 in Multiple Sclerosis
11/26/2012 11:26:40 AM
More...
|
Apitope to Present At the "Therapeutic & Preventative Vaccines for Autoimmune Diseases: Scientific & Commercial Opportunities" Symposium on 9 January 2011, 2.45pm (Pst)
1/7/2011 10:40:58 AM
More...
|
Apitope Appoints Dr Martin Sims as Research Director
1/5/2011 10:42:11 AM
More...
|
Apitope Appoints Hayley French as Commercial Director
11/1/2010 1:43:10 PM
More...
|
Apitope Grows Operations with Move to St Brandon's House, Bristol, UK
10/1/2010 12:14:21 PM
More...
|
Apitope Presenting At The Peptide Conference On 30 March 2010
3/30/2010 4:09:18 PM
More...
|
Apitope Hires Dr. Graham Roberts as Development Director for Therapeutics
7/16/2009 11:49:06 AM
More...
|
Apitope Raises EUR 10 Million in Series A Financing
10/22/2008 6:49:46 AM
More...
|